Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
mood:1-depression:geriatric [on November 14, 2023]
psychdb [Vitamin B12 Deficiency]
mood:1-depression:geriatric [on January 18, 2024]
psychdb [Pharmacotherapy]
Line 114: Line 114:
 <panel type="​info"​ title="​Pharmacotherapy for Geriatric Depression"​ subtitle="​Lam,​ R. W. et al. (2017). Response to Letter Regarding CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression. The Canadian Journal of Psychiatry, 62(5), 353-354.*"​ no-body="​true"​ footer="​* = Note that the originally published CANMAT 2016 Guidelines '​Section 6. Special populations:​ Youth, women, and the elderly.'​ had several typographical errors and errata. This table references the corrected response letter with an updated table. See reference above for details.">​ <panel type="​info"​ title="​Pharmacotherapy for Geriatric Depression"​ subtitle="​Lam,​ R. W. et al. (2017). Response to Letter Regarding CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression. The Canadian Journal of Psychiatry, 62(5), 353-354.*"​ no-body="​true"​ footer="​* = Note that the originally published CANMAT 2016 Guidelines '​Section 6. Special populations:​ Youth, women, and the elderly.'​ had several typographical errors and errata. This table references the corrected response letter with an updated table. See reference above for details.">​
 | **1st Step**\\ (use one or more agents in sequence) ​                                          | **Monotherapy**:​ [[meds:​antidepressants:​snri:​duloxetine|duloxetine]],​ [[meds:​antidepressants:​nassa:​mirtazapine|mirtazapine]],​ [[meds:​antidepressants:​ssri:​sertraline|sertraline]],​ [[meds:​antidepressants:​snri:​venlafaxine|venlafaxine]],​ [[meds:​antidepressants:​serotonin-modulator:​vortioxetine|vortioxetine]],​ [[meds:​antidepressants:​ssri:​citalopram|citalopram]],​ [[meds:​antidepressants:​snri:​v-desvenlafaxine|desvenlafaxine]],​ [[meds:​antidepressants:​ssri:​escitalopram|escitalopram]] ​                                                                                                                                                                                                     | | **1st Step**\\ (use one or more agents in sequence) ​                                          | **Monotherapy**:​ [[meds:​antidepressants:​snri:​duloxetine|duloxetine]],​ [[meds:​antidepressants:​nassa:​mirtazapine|mirtazapine]],​ [[meds:​antidepressants:​ssri:​sertraline|sertraline]],​ [[meds:​antidepressants:​snri:​venlafaxine|venlafaxine]],​ [[meds:​antidepressants:​serotonin-modulator:​vortioxetine|vortioxetine]],​ [[meds:​antidepressants:​ssri:​citalopram|citalopram]],​ [[meds:​antidepressants:​snri:​v-desvenlafaxine|desvenlafaxine]],​ [[meds:​antidepressants:​ssri:​escitalopram|escitalopram]] ​                                                                                                                                                                                                     |
-| **2nd Step**\\ (if multiple 1st-step treatments are not effective or not indicated) ​          | **Switch to:** [[meds:​antidepressants:​tca:​nortriptyline|nortriptyline]],​ [[meds:​antidepressants:​ssri:​fluoxetine|fluoxetine]],​ [[meds:​antidepressants:​maoi:​moclobemide|moclobemide]],​ [[meds:​antidepressants:​ssri:​paroxetine|paroxetine]],​ [[meds:​antidepressants:​maoi:​phenelzine|phenelzine]],​ [[meds:​antipsychotics:​second-gen-atypical:​6-quetiapine|quetiapine]],​ [[meds:​antidepressants:​sari:​trazodone|trazodone]],​ [[meds:​antidepressants:​ndri:​bupropion|bupropion]] \\ **Or combine with:** [[meds:​antipsychotics:​second-gen-atypical:​3-aripiprazole|aripiprazole]],[([[https://​www.nejm.org/​doi/​full/​10.1056/​NEJMoa2204462|Lenze,​ E. J., Mulsant, B. H., Roose, S. P., Lavretsky, H., Reynolds III, C. F., Blumberger, D. M., ... & Karp, J. F. (2023). Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression. New England Journal of Medicine.]])] [[meds:​stimulants:​2-methylphenidate:​home|methylphenidate]],​ [[meds:​mood-stabilizers-anticonvulsants:​1-lithium|lithium]] ​ |+| **2nd Step**\\ (if multiple 1st-step treatments are not effective or not indicated) ​          | **Switch to:** [[meds:​antidepressants:​tca:​nortriptyline|nortriptyline]],​ [[meds:​antidepressants:​ssri:​fluoxetine|fluoxetine]],​ [[meds:​antidepressants:​maoi:​moclobemide|moclobemide]],​ [[meds:​antidepressants:​ssri:​paroxetine|paroxetine]],​ [[meds:​antidepressants:​maoi:​phenelzine|phenelzine]],​ [[meds:​antipsychotics:​second-gen-atypical:​6-quetiapine|quetiapine]],​ [[meds:​antidepressants:​sari:​trazodone|trazodone]],​ [[meds:​antidepressants:​ndri:​bupropion|bupropion]] \\ **Or combine with:** [[meds:​antipsychotics:​second-gen-atypical:​3-aripiprazole|aripiprazole]] ​(2.5 to 15 mg)[([[https://​www.nejm.org/​doi/​full/​10.1056/​NEJMoa2204462|Lenze,​ E. J., Mulsant, B. H., Roose, S. P., Lavretsky, H., Reynolds III, C. F., Blumberger, D. M., ... & Karp, J. F. (2023). Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression. New England Journal of Medicine.]])][[meds:​stimulants:​2-methylphenidate:​home|methylphenidate]],​ [[meds:​mood-stabilizers-anticonvulsants:​1-lithium|lithium]] ​ |
 | **3rd Step**\\ (if multiple 1st- and 2nd-step treatments are not effective or not indicated) ​ | **Switch to:** [[meds:​antidepressants:​tca:​amitriptyline|amitriptyline]],​ [[meds:​antidepressants:​tca:​imipramine|imipramine]]\\ **Or combine with:** an [[meds:​antidepressants:​ssri:​home|SSRI]] or [[meds:​antidepressants:​snri:​home|SNRI]] with [[meds:​antidepressants:​ndri:​bupropion|bupropion]] ​                                                                                                                                                                                                                                                                                                                                                                                                   | | **3rd Step**\\ (if multiple 1st- and 2nd-step treatments are not effective or not indicated) ​ | **Switch to:** [[meds:​antidepressants:​tca:​amitriptyline|amitriptyline]],​ [[meds:​antidepressants:​tca:​imipramine|imipramine]]\\ **Or combine with:** an [[meds:​antidepressants:​ssri:​home|SSRI]] or [[meds:​antidepressants:​snri:​home|SNRI]] with [[meds:​antidepressants:​ndri:​bupropion|bupropion]] ​                                                                                                                                                                                                                                                                                                                                                                                                   |
 </​panel>​ </​panel>​